High-sensitivity troponin: where are we now and where do we go from here?

Abstract

High-sensitivity troponin (hsTn) assays are used clinically in most parts of the world and are expected to be approved by the US FDA for clinical use in the USA soon. Clinical use of hsTn leads to improvements in the detection of myocardial injury, shorter time to ruling out acute myocardial infarction, improved risk-stratification of patients with heart… (More)
DOI: 10.2217/bmm.14.54

Topics

  • Presentations referencing similar topics